Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Izokibep Dose-finding Study in Moderate-to-Severe Plaque Psoriasis
NCT03591887Phase 2Completed
- Sponsor
- Affibody Medical AB
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of izokibep in plaque psoriasis, sponsored by Affibody Medical AB. Started Mar 2018; status: completed.
02
Drugs
izokibep
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03591887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591887.